BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16741291)

  • 1. Increased cholesterol biosynthesis and hypercholesterolemia in mice overexpressing squalene synthase in the liver.
    Okazaki H; Tazoe F; Okazaki S; Isoo N; Tsukamoto K; Sekiya M; Yahagi N; Iizuka Y; Ohashi K; Kitamine T; Tozawa R; Inaba T; Yagyu H; Okazaki M; Shimano H; Shibata N; Arai H; Nagai RZ; Kadowaki T; Osuga J; Ishibashi S
    J Lipid Res; 2006 Sep; 47(9):1950-8. PubMed ID: 16741291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
    Ness GC; Zhao Z; Keller RK
    Arch Biochem Biophys; 1994 Jun; 311(2):277-85. PubMed ID: 7911291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cholesterol-lowering and transient liver dysfunction in mice lacking squalene synthase in the liver.
    Nagashima S; Yagyu H; Tozawa R; Tazoe F; Takahashi M; Kitamine T; Yamamuro D; Sakai K; Sekiya M; Okazaki H; Osuga J; Honda A; Ishibashi S
    J Lipid Res; 2015 May; 56(5):998-1005. PubMed ID: 25755092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway.
    Do R; Kiss RS; Gaudet D; Engert JC
    Clin Genet; 2009 Jan; 75(1):19-29. PubMed ID: 19054015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.
    Ishibashi S; Brown MS; Goldstein JL; Gerard RD; Hammer RE; Herz J
    J Clin Invest; 1993 Aug; 92(2):883-93. PubMed ID: 8349823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic lethality and defective neural tube closure in mice lacking squalene synthase.
    Tozawa R; Ishibashi S; Osuga J; Yagyu H; Oka T; Chen Z; Ohashi K; Perrey S; Shionoiri F; Yahagi N; Harada K; Gotoda T; Yazaki Y; Yamada N
    J Biol Chem; 1999 Oct; 274(43):30843-8. PubMed ID: 10521476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor.
    Lambert G; Jarnoux AL; Pineau T; Pape O; Chetiveaux M; Laboisse C; Krempf M; Costet P
    Endocrinology; 2006 Oct; 147(10):4985-95. PubMed ID: 16794006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin, tumor necrosis factor, and interleukin-1 decrease hepatic squalene synthase activity, protein, and mRNA levels in Syrian hamsters.
    Memon RA; Shechter I; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
    J Lipid Res; 1997 Aug; 38(8):1620-9. PubMed ID: 9300784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of acyl-coenzyme A:cholesterol acyltransferase-1 in the control of hepatic very low density lipoprotein secretion and low density lipoprotein receptor expression in the mouse and hamster.
    Spady DK; Willard MN; Meidell RS
    J Biol Chem; 2000 Sep; 275(35):27005-12. PubMed ID: 10869364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertriglyceridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance.
    Ng DS; Xie C; Maguire GF; Zhu X; Ugwu F; Lam E; Connelly PW
    J Biol Chem; 2004 Feb; 279(9):7636-42. PubMed ID: 14668345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of mRNA levels of cholesterol biosynthesis enzymes and LDL receptor using ribonuclease protection assay.
    Shimokawa T; Kawabe Y; Honda M; Yazaki Y; Matsumoto A; Itakura H; Kodama T
    J Lipid Res; 1995 Sep; 36(9):1919-24. PubMed ID: 8558080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased rate of cholesterologenesis--a possible cause of hypercholesterolemia in experimental chronic renal failure in rats.
    Szolkiewicz M; Sucajtys E; Chmielewski M; Wolyniec W; Rutkowski P; Boguslawski W; Swierczynski J; Rutkowski B
    Horm Metab Res; 2002 May; 34(5):234-7. PubMed ID: 12063635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation.
    Ness GC; Zhao Z; Lopez D
    Arch Biochem Biophys; 1996 Jan; 325(2):242-8. PubMed ID: 8561503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compensatory responses to inhibition of hepatic squalene synthase.
    Lopez D; Chambers CM; Keller RK; Ness GC
    Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead nitrate-induced development of hypercholesterolemia in rats: sterol-independent gene regulation of hepatic enzymes responsible for cholesterol homeostasis.
    Kojima M; Masui T; Nemoto K; Degawa M
    Toxicol Lett; 2004 Dec; 154(1-2):35-44. PubMed ID: 15475176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia.
    Jones C; Garuti R; Michaely P; Li WP; Maeda N; Cohen JC; Herz J; Hobbs HH
    J Clin Invest; 2007 Jan; 117(1):165-74. PubMed ID: 17200716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute P-407 administration to mice causes hypercholesterolemia by inducing cholesterolgenesis and down-regulating low-density lipoprotein receptor expression.
    Leon C; Wasan KM; Sachs-Barrable K; Johnston TP
    Pharm Res; 2006 Jul; 23(7):1597-607. PubMed ID: 16783477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squalene synthetase activity in human fibroblasts: regulation via the low density lipoprotein receptor.
    Faust JR; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5018-22. PubMed ID: 228272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.